IMRA

Q: What is the price of Imara (IMRA) today?

The current price of Imara (IMRA) is $ 15.57, representing a 0% gain over the past year. The stock began the year trading around $ 14.47 and is currently priced at $ 15.57. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Imara (IMRA) pay dividends?

Imara (IMRA) distributed dividends in the last year,in the months of January and March totaling $ 0.76. The Dividend Yield for the last 12 months is 180.35%.

Q: Is Imara (IMRA) a good investment?

Imara (IMRA) is currently trading at $ 15.57 with a P/E ratio of 69.00%. This represents a -352% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.76 in dividends, resulting in a dividend yield of 180.35%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Imara Inc.

Price

$ 15.57

return (12m)

0.00%

p/e

69.00

p/bv

1.14

DIVIDEND YIELD

180.35%

IMRA price

IMRA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment IMRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

17.27%

3 months

-7.36%

1 year

0.00%

2 years

0.00%

5 years

13.83%

10 years

0.00%

Fundamentals IMRA

review the fundamentals of Imara shares

P/E

69.00

Sector: -2.29 Industry: 10.92

P/S (PSR)

Sector: 1.99 Industry: 1.60

P/BV

1.14

Sector: 2.18 Industry: 3.07

DIVIDEND YIELD (DY)

180.35%

Sector: - Industry: 0.01%

ROA

1.62%

Sector: -26.05% Industry: 2.70%

ROE

1.65%

Sector: -29.81% Industry: 5.25%

ROIC

Sector: -416.93% Industry: -2.27%

NET MARGIN

0.00%

Sector: -28.23% Industry: 2.71%

GROSS MARGIN

0.00%

Sector: 44.66% Industry: 28.76%

OPERATING MARGIN

0.00%

Sector: -23.34% Industry: 1.39%

EV/EBITDA

51.18

Sector: -0.62 Industry: 4.03

EV/EBIT

73.60

Sector: -1.80 Industry: 2.44

PRICE-TO-ASSETS

1.12

Sector: 1.17 Industry: 1.44

BVPS

13.66

Sector: 3.79 Industry: 11.41

EPS

0.23

Sector: -0.90 Industry: 1.09

EQUITY-TO-ASSETS RATIO

0.98

Sector: 0.43 Industry: 0.46

LIABILITIES / ASSETS

0.02

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Imara ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 15.57

Fair Value

$ 0.00

Upside/Downside Return potential.

-45.98%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IMRA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	58.32	9.28	15.92%	0.00%	$ 166.57 B	28.38%
TMO	29.53	3.70	12.52%	0.33%	$ 198.00 B	15.05%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
BSX	32.87	0.00	0.00%	0.00%	$ 95.25 B	14.44%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
HCA	16.40	-40.15	-244.82%	0.60%	$ 111.26 B	8.97%
IDXX	44.49	29.36	65.99%	0.00%	$ 47.14 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
DHR	38.10	2.62	6.88%	0.66%	$ 137.69 B	14.71%
INMD	9.84	1.35	13.73%	0.00%	$ 922.95 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IMRA Historical Dividends

current DY: 180.35%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/27/2026	03/31/2026	0,25000000
Dividends	02/27/2026	03/03/2026	0,30590000
Dividends	01/23/2026	01/27/2026	0,20800000
Dividends	12/26/2025	12/30/2025	1,41700000
Dividends	11/28/2025	12/02/2025	1,69400000
Dividends	10/24/2025	10/28/2025	3,01200000
Dividends	09/26/2025	09/30/2025	3,20000000
Dividends	08/22/2025	08/26/2025	2,90000000
Dividends	07/25/2025	07/29/2025	3,86500000
Dividends	06/27/2025	07/01/2025	1,89000000
Dividends	05/23/2025	05/28/2025	9,33000000

ABOUT Imara

Imara Inc.

Average Investor10 user rating

4.0 (3 people)

United States

10 years

Founded: 2016

2020

Time since IPO - 6 years

27

Employees

Imara Inc. (United States) is listed on the Nasdaq and has a market capitalization of $102.67 Millions, with shareholders equity totaling $90.13 Millions.

The company employs approximately 27 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Imara Inc. reported $- in revenue, generating net income of $1.49 Million.

Key financial metrics include a P/E ratio of 69.00, a price-to-book (P/B) ratio of 1.14, and a trailing twelve-month dividend yield of 180.35%.

The company trades under the ticker IMRA.

Market cap

$ 102.67 Millions

Net worth

$ 90.13 Millions

$ 90,129,000.00

Assets

$ 91.96 Millions

$ 91,959,000.00

Total Shares Outstanding

6.60 Millions

6,596,000

Average Daily Trading Volume

$ 5.16 Thousand

$ 5,159.26

Sector

Health

Industry

Medical Supplies and Equipment

IMRA

IMRA revenue and profits

Financial Results IMRA

DRAG THE FRAME TO SEE MORE DATA

IMRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.30 20,29% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 278.64 --13,81% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 38.17 --37,12% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 205.14 --20,95% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

HCA - HCA Healthcare

$ 488.00 46,66% (12M)

P/E

16.40

0.60%

ROE

-244.82%

P/BV

-40.15

LLY - Eli Lilly

$ 927.03 14,15% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 151.97 44,80% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25